• Mashup Score: 0

    KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD By Jai Luo, MD Hi there, my name is Jai Luo. I’m a thoracic medical oncologist at Dana Farber. It’s very nice to speak with you today about my talk at ASCO called, Taking on Goliath: Targeting KRAS in Lung Cancer. The meaning behind Goliath here is that it…

    Tweet Tweets with this article
    • An insightful discussion on taking on the challenge of KRAS lung cancer by Jai Luo, MD. 🥼 The interview explores KRAS lung cancer 🫁 therapy and its significant advances. Watch now on OncologyTube! https://t.co/uRqoEvQkwd @Jia_Luo @DanaFarber @harvardmed #ASCO22 https://t.co/HM9oxXN5c4

  • Mashup Score: 0

    T-Vec: + Pembro Advanced Melanoma MASTERKEY-115 Trial Dr Gastman By Brian Gastman, MD The FDA’s approval of multiple drugs for the treatment of metastatic unresectable melanoma led to the concept that we should certainly interrogate whether combinations of these drugs could work synergistically together. Amgen start…

    Tweet Tweets with this article
    • An insightful video on #AdvancedMelanoma treatment options featuring Dr. Gastman discussing the #TVEC & #Pembro combo in the Masterkey-115 trial. OncologyTube https://t.co/fk7d7IOoRV @BrianGastmanMD @GastmanLab @CleClinicLCM #ASCO22 https://t.co/oNA3UcLJLV

  • Mashup Score: 0

    AuthorsChristine HoRoswell Park Comprehensive Cancer Center, Buffalo, NYChristine Ho, Paul K. Wallace, Kristopher Attwood, Sarah Parker, Hemn Mohammadpour, Megan Herr, George Chen, Joseph Tario, Philip L. McCarthy, Jens HillengassOrganizationsRoswell Park Comprehensive Cancer Center, Buffalo, NY, Roswell Park Comprehensive Cancer Center, Transplant and Cellular Therapy Program, Department of…

    Tweet Tweets with this article
    • Immune cell differences between patients in different stages of monoclonal plasma cell disorders - Ho et al. #ASCO22 Abstract 8065 https://t.co/TsSdwNPcLr #ImmunoOnc #mmsm https://t.co/z33Pt9hvZw

  • Mashup Score: 1

    AuthorsGhulam Rehman MohyuddinUniversity of Utah, Salt Lake City, UTGhulam Rehman Mohyuddin, Jennifer M. Ahlstrom, Cynthia Chmielewski, Nathan W. Sweeney, Thomas H. Molina, Christian S. Cheung, Emily Watabe Ballard, Felicia Seng, Amandeep Godara, Brian McClune, Douglas W. SborovOrganizationsUniversity of Utah, Salt Lake City, UT, HealthTree Foundation, Lehi, UT, The Myeloma Crowd, Lawrenceville,…

    Tweet Tweets with this article
    • A patient perspective on cure in multiple myeloma: A survey of over 1,500 patients - @ManniMD1 @AhlstromJenny @MyelomaTeacher @NSweeneyPhd et al. Abstract 8046 #ASCO22 https://t.co/tV1eFYXmDw #mmsm https://t.co/oR6dsFarpm

  • Mashup Score: 1

    This study that we presented at ASCO is titled a descriptive study on the treatment and outcomes of patients with platinum sensitive advanced BRCA or PALB2 related pancreatic cancers who have progressed on recappery so basically what this study wa…

    Tweet Tweets with this article
    • Learn the link between BRCA1, BRCA2, PALB2 gene mutations and pancreatic cancer. #cancer #genetics #pancreaticcancer @TimothyJBrownMD @KReissMD @PennCancer #ASCO22 Watch video here: https://t.co/OtTUYMilnC.?channelName=AnnualCancerMeeting#gsc.tab=0 https://t.co/9POEndcMZr

  • Mashup Score: 1

    AuthorsChristine HoRoswell Park Comprehensive Cancer Center, Buffalo, NYChristine Ho, Paul K. Wallace, Kristopher Attwood, Sarah Parker, Hemn Mohammadpour, Megan Herr, George Chen, Joseph Tario, Philip L. McCarthy, Jens HillengassOrganizationsRoswell Park Comprehensive Cancer Center, Buffalo, NY, Roswell Park Comprehensive Cancer Center, Transplant and Cellular Therapy Program, Department of…

    Tweet Tweets with this article
    • Immune cell differences between patients in different stages of monoclonal plasma cell disorders - Ho et al. #ASCO22 Abstract 8065 https://t.co/TsSdwNPKAZ #ImmunoOnc #mmsm